Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
Adial Pharmaceuticals (ADIL) Stock Price & Analysis
267 Followers
ADIL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $2.27
Previous Close$0.42
Volume165.55K
Average Volume (3M)779.71K
Market Cap
$11.83M
Enterprise Value$6.30M
Total Cash (Recent Filing)$5.75M
Total Debt (Recent Filing)$220.25K
Price to Earnings (P/E)-0.6
Beta0.07
Next Earnings
Nov 14, 2022EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding26,853,962
10 Day Avg. Volume141,926
30 Day Avg. Volume779,708
Standard Deviation0.33
R-Squared0.03
Alpha-0.00516
Financial Highlights & Ratios
Price to Book (P/B)2.46
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Adial Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADIL FAQ
What was Adial Pharmaceuticals Inc’s price range in the past 12 months?
Adial Pharmaceuticals Inc lowest stock price was $0.20 and its highest was $2.27 in the past 12 months.
What is Adial Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Adial Pharmaceuticals Inc’s upcoming earnings report date?
Adial Pharmaceuticals Inc’s upcoming earnings report date is Nov 14, 2022 which is 128 days ago.
How were Adial Pharmaceuticals Inc’s earnings last quarter?
Adial Pharmaceuticals Inc released its earnings results on May 16, 2022. The company reported -$0.13 earnings per share for the quarter, beating the consensus estimate of -$0.17 by $0.04.
Is Adial Pharmaceuticals Inc overvalued?
According to Wall Street analysts Adial Pharmaceuticals Inc’s price is currently Overvalued.
Does Adial Pharmaceuticals Inc pay dividends?
Adial Pharmaceuticals Inc does not currently pay dividends.
What is Adial Pharmaceuticals Inc’s EPS estimate?
Adial Pharmaceuticals Inc’s EPS estimate is -$0.18.
How many shares outstanding does Adial Pharmaceuticals Inc have?
Adial Pharmaceuticals Inc has 28,516,563 shares outstanding.
What happened to Adial Pharmaceuticals Inc’s price movement after its last earnings report?
Adial Pharmaceuticals Inc reported an EPS of -$0.13 in its last earnings report, beating expectations of -$0.17. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adial Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ADIL
---
Adial Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
ADIL Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 15.0%
Last 30 Days ▲ 15.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.71%
12-Months-Change
Fundamentals
Return on Equity
-248.96%
Trailing 12-Months
Asset Growth
-25.89%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adial Pharmaceuticals Inc
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which is focused on the treatment of alcohol use disorder. Its lead product AD04, a selective serotonin-3 antagonist is in Phase 3 clinical trial. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.
---
---